Märkte & Kurse

    Medacta Group SA publishes 2026 Annual General Meeting invitation

^
Medacta Group SA / Schlagwort(e): Generalversammlung/Generalversammlung
Medacta Group SA publishes 2026 Annual General Meeting invitation

07.04.2026 / 10:00 CET/CEST

---------------------------------------------------------------------------

Press Release

Medacta Group SA publishes 2026 Annual General Meeting invitation

CASTEL SAN PIETRO, 07 April 2026 - Medacta Group SA ("Medacta", SIX:MOVE)
published today the invitation to the Annual General Meeting ("AGM") which
will take place at the Group premises in Via alla Rossa 6, Rancate,
Switzerland on Tuesday, 5 May 2026 at 11.00 am.

Shareholders can register to attend the Annual General Meeting in person but
will also be able to vote their shares by giving a power of attorney and
related voting instructions to the independent proxy or to a third-party
proxy (who needs not be a shareholder).

Shareholders will be given the opportunity to submit questions to the Board
of Directors ahead of the Annual General Meeting on Agenda Items via email
to investor.relations@medacta.ch .

The Board of Directors is proposing to the AGM the distribution of CHF 21.9
million or CHF 1.10 per share, to be distributed as dividend out of
available earnings.

The Board is proposing the re-election of Dr. Alberto Siccardi as Chairman
of the Board of Directors as well as of the other current board members, all
of whom stand for re-election.

The Board is also proposing the re-election of the members of the
Remuneration Committee and the approval of the maximum amount of
compensations for the members of the Board of Directors and the Group
Executive Management. Further motions include the re-election of the
Independent Proxy Holder and Auditors for the financial year 2026.

All details on the motions can be found in the invitation to the 2026 AGM at
https://www.medacta.com/EN/agm.

Contact

Medacta Investor Relations
Telephone: +41 91 696 6060
investor.relations@medacta.ch

About Medacta

Medacta is a global key player specializing in the design, production, and
distribution of innovative, personalized, and sustainable solutions for
joint replacement, sports medicine, and spine surgery. Established in 1999
in Switzerland, Medacta is committed to improving the care and well-being of
patients and maintains a strong focus on healthcare sustainability. Through
close collaboration with expert surgeons globally, continuous investments in
R&D, and the adoption of cutting-edge technologies, Medacta's innovation
prioritizes minimally invasive surgery and personalized solutions for every
patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a
comprehensive and tailored program dedicated to the advancement of medical
education. Medacta is headquartered in Castel San Pietro, Switzerland.
Follow us on Medacta.com, Medacta TV, YouTube, LinkedIn and X.


---------------------------------------------------------------------------

Ende der Medienmitteilungen
Originalinhalt anzeigen:
https://eqs-news.com/?origin_id=acfd94f4-29f1-11f1-8534-027f3c38b923&lang=de

---------------------------------------------------------------------------

   Sprache:        Deutsch
   Unternehmen:    Medacta Group SA
                   Strada Regina
                   6874 Castel San Pietro
                   Schweiz
   Telefon:        +41 91 696 6060
   E-Mail:         info@medacta.ch
   Internet:       www.medacta.com
   ISIN:           CH0468525222
   Börsen:         SIX Swiss Exchange
   EQS News ID:    2299572



   Ende der Mitteilung    EQS News-Service
---------------------------------------------------------------------------

2299572 07.04.2026 CET/CEST

°